UA86082C2 - Производные 4-арилморфолин-3-она, способ их получения и их применение в терапии - Google Patents

Производные 4-арилморфолин-3-она, способ их получения и их применение в терапии

Info

Publication number
UA86082C2
UA86082C2 UAA200701878A UAA200701878A UA86082C2 UA 86082 C2 UA86082 C2 UA 86082C2 UA A200701878 A UAA200701878 A UA A200701878A UA A200701878 A UAA200701878 A UA A200701878A UA 86082 C2 UA86082 C2 UA 86082C2
Authority
UA
Ukraine
Prior art keywords
derivatives
therapeutic use
unsubstituted
arylmorpholin
preparation
Prior art date
Application number
UAA200701878A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ксавье Эмон-Альт
Винченцо Проиетто
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Publication of UA86082C2 publication Critical patent/UA86082C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Объектом изобретения являются соединения формулы (І), в которой: Аr означает фенил, моно- или двузамещенный;Rозначает фенил, незамещенный или замещенный;Rозначает: пиридил; фенил, незамещенный или замещенный; бензил, незамещенный или замещенный по фенилу;кроме того, Rможет означать гетероциклический радикал;Rимеет разные значения.Способ получения и применение в терапии.(І)
UAA200701878A 2004-07-23 2005-07-20 Производные 4-арилморфолин-3-она, способ их получения и их применение в терапии UA86082C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408222A FR2873373B1 (fr) 2004-07-23 2004-07-23 Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
UA86082C2 true UA86082C2 (ru) 2009-03-25

Family

ID=34951659

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200701878A UA86082C2 (ru) 2004-07-23 2005-07-20 Производные 4-арилморфолин-3-она, способ их получения и их применение в терапии

Country Status (29)

Country Link
US (1) US7521449B2 (ru)
EP (1) EP1773823B1 (ru)
JP (1) JP4812759B2 (ru)
KR (1) KR20070034066A (ru)
CN (1) CN101006084B (ru)
AR (1) AR050262A1 (ru)
AU (1) AU2005276352A1 (ru)
BR (1) BRPI0513581A (ru)
CA (1) CA2573446A1 (ru)
CR (1) CR8843A (ru)
EA (1) EA011035B1 (ru)
EC (1) ECSP077181A (ru)
FR (1) FR2873373B1 (ru)
GT (1) GT200500196A (ru)
HN (1) HN2005000380A (ru)
IL (1) IL180484A0 (ru)
MA (1) MA28741B1 (ru)
MX (1) MX2007000814A (ru)
MY (1) MY142757A (ru)
NO (1) NO20071020L (ru)
PA (1) PA8640101A1 (ru)
PE (1) PE20060553A1 (ru)
SV (1) SV2006002176A (ru)
TN (1) TNSN06438A1 (ru)
TW (1) TW200603800A (ru)
UA (1) UA86082C2 (ru)
UY (1) UY29022A1 (ru)
WO (1) WO2006021654A1 (ru)
ZA (1) ZA200700603B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912058A1 (fr) * 2007-02-07 2008-08-08 Sanofi Aventis Sa Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles
WO2015200594A2 (en) 2014-06-25 2015-12-30 Emory University Methods of managing conditioned fear with neurokinin receptor antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2751654B1 (fr) * 1996-07-26 1998-10-23 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2738819B1 (fr) * 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
HU224225B1 (hu) * 1995-12-01 2005-06-28 Sankyo Co. Ltd. Tachikinin receptor antagonista hatású heterociklusos vegyületek, ezek előállítási eljárása és alkalmazásuk gyógyszerkészítmények előállítására
GB9601680D0 (en) * 1996-01-27 1996-03-27 Pfizer Ltd Therapeutic agents
DE69830615T2 (de) * 1997-12-04 2006-03-16 Sankyo Co., Ltd. Alicyclische acylierte heterocyclenderivate
JPH11240880A (ja) * 1997-12-04 1999-09-07 Sankyo Co Ltd 脂環式アシル化複素環誘導体
GB9812037D0 (en) * 1998-06-04 1998-07-29 Pfizer Ltd Piperidones
FR2789390B3 (fr) * 1999-02-10 2001-03-09 Sanofi Sa Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
FR2791346B3 (fr) * 1999-03-25 2001-04-27 Sanofi Sa Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
ES2258485T3 (es) * 1999-12-17 2006-09-01 Schering Corporation Antagonistas selectivos de neuroquinina.
FR2824828B1 (fr) * 2001-05-21 2005-05-20 Sanofi Synthelabo Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant
GB0130261D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Lactams as tachykinin antagonists

Also Published As

Publication number Publication date
WO2006021654A8 (fr) 2007-05-24
EP1773823B1 (fr) 2013-08-21
TNSN06438A1 (fr) 2008-02-22
FR2873373B1 (fr) 2006-09-08
PA8640101A1 (es) 2006-03-24
JP4812759B2 (ja) 2011-11-09
IL180484A0 (en) 2007-06-03
ZA200700603B (en) 2008-10-29
EA200700098A1 (ru) 2007-06-29
JP2008507497A (ja) 2008-03-13
US20070142349A1 (en) 2007-06-21
SV2006002176A (es) 2006-01-13
PE20060553A1 (es) 2006-07-04
NO20071020L (no) 2007-02-22
UY29022A1 (es) 2006-02-24
HK1107340A1 (en) 2008-04-03
FR2873373A1 (fr) 2006-01-27
MY142757A (en) 2010-12-31
AU2005276352A1 (en) 2006-03-02
ECSP077181A (es) 2007-02-28
HN2005000380A (es) 2009-05-14
GT200500196A (es) 2006-03-02
CN101006084B (zh) 2010-09-08
CN101006084A (zh) 2007-07-25
AR050262A1 (es) 2006-10-11
CA2573446A1 (fr) 2006-03-02
BRPI0513581A (pt) 2008-05-13
TW200603800A (en) 2006-02-01
CR8843A (es) 2007-08-28
US7521449B2 (en) 2009-04-21
MX2007000814A (es) 2007-04-02
WO2006021654A1 (fr) 2006-03-02
EA011035B1 (ru) 2008-12-30
EP1773823A1 (fr) 2007-04-18
MA28741B1 (fr) 2007-07-02
KR20070034066A (ko) 2007-03-27

Similar Documents

Publication Publication Date Title
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
IL174210A0 (en) 1,4 disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
AU2002246728A1 (en) Carboline derivatives
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
UA93351C2 (ru) Производные фталазина kak ингибиторы parp
ATE478044T1 (de) Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c
IL185611A0 (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
WO2006028958A3 (en) Pyridyl inhibitors of hedgehog signalling
TW200604179A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
AU2002249890A1 (en) Carboline derivatives
TW200637822A (en) Process for the preparation of a 2-pyridylethylcarboxamide derivative
TW200640900A (en) 1-(2h)-isoquinolone derivative
DE602005020666D1 (en) Mif-hemmer
TW200633981A (en) Process for the preparation of a 2-ethylaminopyridine derivative
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
UA86082C2 (ru) Производные 4-арилморфолин-3-она, способ их получения и их применение в терапии
WO2004045282A3 (de) Fungizide mischungen auf der basis eines triazolopyrimidin-derivates und amidverbindungen
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
MXPA05007579A (es) Derivados de 9-cetoespinosin.
TW200633997A (en) Substituted heterocyclic compounds and thrombopoietin receptor activators
WO2001011968A3 (en) Heterocyclic spiro compounds as pesticides